New vaccine combo aims to slow Alzheimer's by targeting tau tangles
Disease control
ENROLLING_BY_INVITATION
This study tests a vaccine called AADvac1, which targets tau tangles in the brain, a hallmark of Alzheimer's. It will be given alone or with another drug (donanemab) to 450 adults aged 50-80 with very early Alzheimer's. The goal is to see if this approach can reduce tau buildup a…
Phase: PHASE2 • Sponsor: Paul S. Aisen • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC